Leitlinie
Guidelines for the Management of Amyloidosis 2025: Key Points on Peripheral Neuropathy
Journal of Nihon University Medical Association · 01.10.2026 · 85 (5) · 193-198
DOI: 10.4264/numa.85.5_193 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Nihon University Medical Association, erschienen am 01.10.2026. Verfasst von Tomotaka Mizoguchi. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mizoguchi, T. (2026). Guidelines for the Management of Amyloidosis 2025: Key Points on Peripheral Neuropathy. Journal of Nihon University Medical Association, 85(5), 193-198. https://doi.org/10.4264/numa.85.5_193
Vancouver
Mizoguchi T. Guidelines for the Management of Amyloidosis 2025: Key Points on Peripheral Neuropathy. Journal of Nihon University Medical Association. 2026;85(5):193-198. doi:10.4264/numa.85.5_193
BibTeX
@article{Mizoguchi2026,
author = {Mizoguchi, Tomotaka},
title = {Guidelines for the Management of Amyloidosis 2025: Key Points on Peripheral Neuropathy},
journal = {Journal of Nihon University Medical Association},
year = {2026},
volume = {85},
number = {5},
pages = {193--198},
doi = {10.4264/numa.85.5_193}
}
EUVIMED